Genetic insight into sick sinus syndrome.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
21 05 2021
Historique:
received: 28 04 2020
revised: 24 08 2020
accepted: 05 01 2021
entrez: 25 10 2022
pubmed: 21 5 2021
medline: 28 10 2022
Statut: ppublish

Résumé

The aim of this study was to use human genetics to investigate the pathogenesis of sick sinus syndrome (SSS) and the role of risk factors in its development. We performed a genome-wide association study of 6469 SSS cases and 1 000 187 controls from deCODE genetics, the Copenhagen Hospital Biobank, UK Biobank, and the HUNT study. Variants at six loci associated with SSS, a reported missense variant in MYH6, known atrial fibrillation (AF)/electrocardiogram variants at PITX2, ZFHX3, TTN/CCDC141, and SCN10A and a low-frequency (MAF = 1.1-1.8%) missense variant, p.Gly62Cys in KRT8 encoding the intermediate filament protein keratin 8. A full genotypic model best described the p.Gly62Cys association (P = 1.6 × 10-20), with an odds ratio (OR) of 1.44 for heterozygotes and a disproportionally large OR of 13.99 for homozygotes. All the SSS variants increased the risk of pacemaker implantation. Their association with AF varied and p.Gly62Cys was the only variant not associating with any other arrhythmia or cardiovascular disease. We tested 17 exposure phenotypes in polygenic score (PGS) and Mendelian randomization analyses. Only two associated with the risk of SSS in Mendelian randomization, AF, and lower heart rate, suggesting causality. Powerful PGS analyses provided convincing evidence against causal associations for body mass index, cholesterol, triglycerides, and type 2 diabetes (P > 0.05). We report the associations of variants at six loci with SSS, including a missense variant in KRT8 that confers high risk in homozygotes and points to a mechanism specific to SSS development. Mendelian randomization supports a causal role for AF in the development of SSS.

Identifiants

pubmed: 36282123
pii: 6772146
doi: 10.1093/eurheartj/ehaa1108
doi:

Substances chimiques

Keratin-8 0
Triglycerides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1959-1971

Investigateurs

Steffen Andersen (S)
Christian Erikstrup (C)
Thomas F Hansen (TF)
Henrik Hjalgrim (H)
Gregor Jemec (G)
Poul Jennum (P)
Mette Nyegaard (M)
Mie T Bruun (MT)
Mikkel Petersen (M)
Thomas Werge (T)
Per I Johansson (PI)

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Rosa B Thorolfsdottir (RB)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Gardar Sveinbjornsson (G)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Hildur M Aegisdottir (HM)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Stefania Benonisdottir (S)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Lilja Stefansdottir (L)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Erna V Ivarsdottir (EV)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Gisli H Halldorsson (GH)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Jon K Sigurdsson (JK)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Christian Torp-Pedersen (C)

Department of Clinical Research and Cardiology, Nordsjaelland Hospital, Dyrehavevej 29, Hillerød 3400, Denmark.

Peter E Weeke (PE)

Department of Cardiology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.

Søren Brunak (S)

Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3A, Copenhagen 2200, Denmark.

David Westergaard (D)

Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3A, Copenhagen 2200, Denmark.

Ole B Pedersen (OB)

Department of Clinical Immunology, Naestved Hospital, Ringstedgade 77B, Naestved 4700, Denmark.

Erik Sorensen (E)

Department of Clinical Immunology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.

Kaspar R Nielsen (KR)

Department of Clinical Immunology, Aalborg University Hospital North, Urbansgade 36, Aalborg 9000, Denmark.

Kristoffer S Burgdorf (KS)

Department of Clinical Immunology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.

Karina Banasik (K)

Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3A, Copenhagen 2200, Denmark.

Ben Brumpton (B)

Department of Thoracic and Occupational Medicine, St. Olavs Hospital, Trondheim University Hospital, Prinsesse Kristinas gate 3, Trondheim 7030, Norway.

Wei Zhou (W)

Department of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218, USA.

Asmundur Oddsson (A)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Vinicius Tragante (V)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Kristjan E Hjorleifsson (KE)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Department of Computing and Mathematical Sciences, California Institute of Technology, 1200 E California Blvd. MC 305-16, Pasadena, CA 91125, USA.

Olafur B Davidsson (OB)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Sridharan Rajamani (S)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Stefan Jonsson (S)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Bjarni Torfason (B)

Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik 101, Iceland.
Department of Cardiothoracic Surgery, Landspitali-The National University Hospital of Iceland, Hringbraut, Reykjavik 101, Iceland.

Atli S Valgardsson (AS)

Department of Cardiothoracic Surgery, Landspitali-The National University Hospital of Iceland, Hringbraut, Reykjavik 101, Iceland.

Gudmundur Thorgeirsson (G)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik 101, Iceland.
Department of Medicine, Landspitali-The National University Hospital of Iceland, Hringbraut, Reykjavik 101, Iceland.

Michael L Frigge (ML)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Gudmar Thorleifsson (G)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Gudmundur L Norddahl (GL)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Anna Helgadottir (A)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Solveig Gretarsdottir (S)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Patrick Sulem (P)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Ingileif Jonsdottir (I)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik 101, Iceland.
Department of Immunology, Landspitali-The National University Hospital of Iceland, Hringbraut, Reykjavik 101, Iceland.

Cristen J Willer (CJ)

Department of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218, USA.
Department of Internal Medicine: Cardiology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109 -5368, USA.
Department of Human Genetics, University of Michigan, 4909 Buhl Building, 1241 E. Catherine St., Ann Arbor, MI 48109 -5618, USA.

Kristian Hveem (K)

K.G. Jebsen Center for Genetic Epidemiology, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Erling Skjalgssons gt. 1, Trondheim 7491, Norway.
Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Postboks 8905, Trondheim 7491, Norway.
HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology, Forskningsveien 2, Levanger 7600, Norway.

Henning Bundgaard (H)

Department of Cardiology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.

Henrik Ullum (H)

Department of Clinical Immunology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.
Statens Serum Institut, Artillerivej 5, Copenhagen 2300, Denmark.

David O Arnar (DO)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik 101, Iceland.
Department of Medicine, Landspitali-The National University Hospital of Iceland, Hringbraut, Reykjavik 101, Iceland.

Unnur Thorsteinsdottir (U)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik 101, Iceland.

Daniel F Gudbjartsson (DF)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
School of Engineering and Natural Sciences, University of Iceland, Hjardarhagi 4, Reykjavik 107, Iceland.

Hilma Holm (H)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.

Kari Stefansson (K)

deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik 101, Iceland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH